BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1967596)

  • 21. Ha-ras polymorphisms in epithelial ovarian cancer.
    O'Briant K; Chrysson N; Hunter V; Tyson F; Tanner M; Daly L; George SL; Berchuck A; Soper J; Fowler W
    Gynecol Oncol; 1992 Jun; 45(3):299-302. PubMed ID: 1351862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma.
    Morimoto Y; Ozaki T; Ouchida M; Umehara N; Ohata N; Yoshida A; Shimizu K; Inoue H
    Cancer; 2003 Nov; 98(10):2245-50. PubMed ID: 14601095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dosage and allelic restriction fragment studies and PCR analysis of the H-ras locus in giant cell tumor of bone.
    Dahir GA; Vnencak-Jones CL; Schwartz HS; Butler MG
    Cancer Genet Cytogenet; 1994 Jun; 74(2):95-8. PubMed ID: 7912645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations of retinoblastoma susceptible gene accompanied by c-myc amplification in human bone and soft tissue tumors.
    Ozaki T; Ikeda S; Kawai A; Inoue H; Oda T
    Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):235-42. PubMed ID: 8513277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution and rearrangements of alleles of c-Ha-ras-1 protooncogene and their correlation with the development of lung, ovarian and thyroid cancers.
    Knyazev PG; Nikiforova IF; Serova OM; Pluzhnikova GF
    Neoplasma; 1990; 37(6):647-55. PubMed ID: 1980342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonrandom distribution of N-myc oncogene genotypes in neuroblastoma.
    Waber PG; Bowcock AM; Arencibia-Mireles O; Nisen PD
    J Natl Cancer Inst; 1991 Aug; 83(15):1085-8. PubMed ID: 1678788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study on Ha-ras RFLPs in gastric carcinoma and normal tissue DNAs of Chinese individuals].
    Shan X; Yan M; Huang Y; Mao Y; Wang S; Zhao S
    Yi Chuan Xue Bao; 1990; 17(2):154-60. PubMed ID: 1978686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence against a tumour-specific EcoRI RFLP of the c-mos locus.
    Corell B; Zoll B
    FEBS Lett; 1988 Mar; 230(1-2):81-4. PubMed ID: 2895024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Restriction polymorphism of the proto-oncogene c-Ha-ras-1 in patients with multiple primary malignant neoplasms and non-small-cell lung cancer].
    Gaspar'ian AV; Sel'chuk VIu; Iakubovskaia MG; Zborovskaia IB; Tatosian AG
    Genetika; 1997 Jan; 33(1):96-100. PubMed ID: 9162692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Frequency and rearrangements of alleles of proto-oncogene c-Ha-ras-1 and their association with development of various malignant tumors in man].
    Nikiforova IF; Serova OM; Pluzhnikova GF; Kniazev PG; Seĭts IF
    Genetika; 1990 Mar; 26(3):531-40. PubMed ID: 1972367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restriction fragment length polymorphism of the L-myc gene and susceptibility to metastasis in renal cancer patients.
    Kakehi Y; Yoshida O
    Int J Cancer; 1989 Mar; 43(3):391-4. PubMed ID: 2564378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas.
    Wunder JS; Czitrom AA; Kandel R; Andrulis IL
    J Natl Cancer Inst; 1991 Feb; 83(3):194-200. PubMed ID: 1988704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A MboII polymorphism in exon 11 of the human MDM2 gene occuring in normal blood donors and in soft tissue sarcoma patients: an indication for an increased cancer susceptibility?
    Taubert H; Kappler M; Meye A; Bartel F; Schlott T; Lautenschläger C; Bache M; Schmidt H; Würl P
    Mutat Res; 2000 Nov; 456(1-2):39-44. PubMed ID: 11087894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Restriction fragment length polymorphism analysis of the L-myc gene locus in a case-control study of lung cancer.
    Tamai S; Sugimura H; Caporaso NE; Resau JH; Trump BF; Weston A; Harris CC
    Int J Cancer; 1990 Sep; 46(3):411-5. PubMed ID: 1975565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel restriction fragment length polymorphisms in the cellular oncogene SEA.
    Koduru PR; Goh JC; Broome JD
    Hematol Pathol; 1992; 6(2):71-8. PubMed ID: 1351480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [DNA polymorphism: comparison of allelic frequencies obtained with two HVR probes in a population from Northeastern Brazil and in two other ethnic groups].
    Soares JA; Van Huffel V; Salmon D; Ruffie J; Salmon C; Rouger P
    Rev Fr Transfus Hemobiol; 1991 Mar; 34(2):107-18. PubMed ID: 1674415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sporadic amplification of the c-fms proto-oncogene in human musculoskeletal sarcomas.
    Castresana JS; Barrios C; Ruiz J; Gómez L; Kreicbergs A
    Anticancer Res; 1993; 13(3):807-10. PubMed ID: 8317916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers.
    Young J; Buttenshaw R; Butterworth L; Ward M; Searle J; Leggett B; Chenevix-Trench G
    Oncogene; 1994 Apr; 9(4):1053-6. PubMed ID: 7907781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. c-Ha-ras polymorphism in patients with hepatocellular carcinoma. Comparison of healthy subjects and alcoholic patients with cirrhosis.
    Thelu MA; Zarski JP; Froissart B; Rachail M; Seigneurin JM
    Gastroenterol Clin Biol; 1993; 17(12):903-7. PubMed ID: 7907302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas.
    Mousses S; McAuley L; Bell RS; Kandel R; Andrulis IL
    Mod Pathol; 1996 Jan; 9(1):1-6. PubMed ID: 8821948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.